Identification of miR-185 as a regulator of de novo cholesterol biosynthesis and low density lipoprotein uptake

Journal of Lipid Research

Volumn 55, Issue 2, 2014, Pages 226-238

  Yang, Muhua ^a   Liu, Weidong ^a   Pellicane, Christina ^a   Sahyoun, Christine ^a   Joseph, Biny K ^a   Gallo Ebert, Christina ^a   Donigan, Melissa ^a   Pandya, Devanshi ^a   Giordano, Caroline ^b   Bata, Adam ^b   Nickels Jr , Joseph T ^a  

^a Genesis Biotechnology Group   (United States)

^b Invivotek   (United States)

Author keywords

Cholesterol; Metabolism; MicroRNA; Sterol response element binding protein; Transcription

Indexed keywords

CHOLESTEROL; METABOLISM; MICRORNA; STEROL RESPONSE ELEMENT BINDING PROTEIN; TRANSCRIPTION;

3' UNTRANSLATED REGIONS; ANIMALS; CELL LINE; CHOLESTEROL; DIET, HIGH-FAT; GENE EXPRESSION REGULATION; HUMANS; HYDROXYMETHYLGLUTARYL COA REDUCTASES; INSULIN; LIPOPROTEINS, LDL; MALE; MICE; MICE, INBRED C57BL; MICRORNAS; ORPHAN NUCLEAR RECEPTORS; PROTEIN TRANSPORT; RECEPTORS, LDL; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; STEROL REGULATORY ELEMENT BINDING PROTEIN 2; TRANSCRIPTION, GENETIC;

EID: 84893357948     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M041335     Document Type: Article

References (83)

1. Saini, H. K., A. S. Arneja, and N. S. Dhalla.2004.Role of cholesterol in cardiovascular dysfunction. Can. J. Cardiol. 20 : 333-346.
2. Glass, C. K., and J. L. Witztum.2001.Atherosclerosis, the road ahead. Cell.104 : 503-516.
3. Brown, M. S., and J. L. Goldstein.1986.A receptor-mediated pathway for cholesterol homeostasis. Science.232 : 34-47.
4. Brown, M. S., and J. L. Goldstein.1976.Receptor-mediated control of cholesterol metabolism. Science.191 : 150-154.
5. Bloch, K. E. 1983.Sterol structure and membrane function. CRC Crit. Rev. Biochem. 14 : 47-92.
6. Shefer, S., S. Hauser, V. Lapar, and E. H. Mosbach.1972.HMG CoA reductase of intestinal mucosa and liver of the rat. J. Lipid Res. 13 : 402-412.
7. Nicolau, G., S. Shefer, G. Salen, and E. H. Mosbach.1974.Determination of hepatic 3-hydroxy-3-methylglutaryl CoA reductase activity in man. J. Lipid Res. 15 : 94-98.
8. Brown, M. S., and J. L. Goldstein.1997.The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membranebound transcription factor. Cell.89 : 331-340.
9. Gasic, G. P. 1994.Basic-helix-loop-helix transcription factor and sterol sensor in a single membrane-bound molecule. Cell.77 : 17-19.
10. Bennett, M. K., J. M. Lopez, H. B. Sanchez, and T. F. Osborne.995.Sterol regulation of fatty acid synthase promoter. Coordinate feedback regulation of two major lipid pathways. J. Biol. Chem. 270 : 25578-25583.
11. Shimomura, I., H. Shimano, J. D. Horton, J. L. Goldstein, and M. S. Brown.1997.Differential expression of exons 1a and 1c in mRNAs for sterol regulatory element binding protein-1 in human and mouse organs and cultured cells. J. Clin. Invest. 99 : 838-845.
12. Brown, M. S., J. Ye, R. B. Rawson, and J. L. Goldstein.2000.Regulated intramembrane proteolysis: a control mechanism conserved from bacteria to humans. Cell.100 : 391-398.
13. Brown, M. S., and J. L. Goldstein.1999.A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood. Proc. Natl. Acad. Sci. USA.96 : 11041-11048.
14. Wang, P. Y., J. Weng, and R. G. Anderson.2005.OSBP is a cholesterol-regulated scaffolding protein in control of ERK 1/2 activation. Science.307 : 1472-1476.
15. Bengoechea-Alonso, M. T., and J. Ericsson.2009.A phosphorylation cascade controls the degradation of active SREBP1. J. Biol. Chem. 284 : 5885-5895.
16. Sundqvist, A., M. T. Bengoechea-Alonso, X. Ye, V. Lukiyanchuk, J. Jin, J. W. Harper, and J. Ericsson.2005.Control of lipid metabolism by phosphorylation-dependent degradation of the SREBP family of transcription factors by SCF(Fbw7). Cell Metab. 1 : 379-391.
17. Kotzka, J., D. Muller-Wieland, A. Koponen, D. Njamen, L. Kremer, G. Roth, M. Munck, B. Knebel, and W. Krone.1998.ADD1/ SREBP-1c mediates insulin-induced gene expression linked to the MAP kinase pathway. Biochem. Biophys. Res. Commun. 249 : 375-379.
18. Kotzka, J., S. Lehr, G. Roth, H. Avci, B. Knebel, and D. Muller-Wieland.2004.Insulin-Activated Erk-mitogen-Activated protein kinases phosphorylate sterol regulatory element-binding protein-2 at serine residues 432 and 455 in vivo. J. Biol. Chem. 279 : 22404-22411.
19. Wong, R. H., and H. S. Sul.2010.Insulin signaling in fatty acid and fat synthesis: a transcriptional perspective. Curr. Opin. Pharmacol. 10 : 684-691.
20. Roth, G., J. Kotzka, L. Kremer, S. Lehr, C. Lohaus, H. E. Meyer, W. Krone, and D. Muller-Wieland.2000.MAP kinases Erk1/2 phosphorylate sterol regulatory element-binding protein (SREBP)-1a at serine 117 in vitro. J. Biol. Chem. 275 : 33302-33307.
21. Lu, M., and J. Y. Shyy.2006.Sterol regulatory element-binding protein 1 is negatively modulated by PKA phosphorylation. Am. J. Physiol. Cell Physiol. 290 : C1477-C1486.
22. Punga, T., M. T. Bengoechea-Alonso, and J. Ericsson.2006.Phosphorylation and ubiquitination of the transcription factor sterol regulatory element-binding protein-1 in response to DNA binding. J. Biol. Chem. 281 : 25278-25286.
23. Bengoechea-Alonso, M. T., and J. Ericsson.2006.Cdk1/cyclin B-mediated phosphorylation stabilizes SREBP1 during mitosis. Cell Cycle.5 : 1708-1718.
24. Kotzka, J., B. Knebel, J. Haas, L. Kremer, S. Jacob, S. Hartwig, U. Nitzgen, and D. Muller-Wieland.2012.Preventing phosphorylation of sterol regulatory element-binding protein 1a by MAP-kinases protects mice from fatty liver and visceral obesity. PLoS ONE.7 : e32609.
25. Kotzka, J., B. Knebel, H. Avci, S. Jacob, U. Nitzgen, F. Jockenhovel, J. Heeren, J. Haas, and D. Muller-Wieland.2010.Phosphorylation of sterol regulatory element-binding protein (SREBP)-1a links growth hormone action to lipid metabolism in hepatocytes. Atherosclerosis.213 : 156-165.
26. Yoon, Y. S., W. Y. Seo, M. W. Lee, S. T. Kim, and S. H. Koo.2009.Salt-inducible kinase regulates hepatic lipogenesis by controlling SREBP-1c phosphorylation. J. Biol. Chem. 284 : 10446-10452.
27. Filipowicz, W., S. N. Bhattacharyya, and N. Sonenberg.2008.Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat. Rev. Genet. 9 : 102-114.
28. Winter, J., S. Jung, S. Keller, R. I. Gregory, and S. Diederichs.2009.Many roads to maturity: microRNA biogenesis pathways and their regulation. Nat. Cell Biol. 11 : 228-234.
29. Chang, T. C., D. Yu, Y. S. Lee, E. A. Wentzel, D. E. Arking, K. M. West, C. V. Dang, A. Thomas-Tikhonenko, and J. T. Mendell.2008.Widespread microRNA repression by Myc contributes to tumorigenesis. Nat. Genet. 40 : 43-50.
30. Marson, A., S. S. Levine, M. F. Cole, G. M. Frampton, T. Brambrink, S. Johnstone, M. G. Guenther, W. K. Johnston, M. Wernig, J. Newman, et al.2008.Connecting microRNA genes to the core transcriptional regulatory circuitry of embryonic stem cells. Cell.134 : 521-533.
31. O'Donnell, K. A., E. A. Wentzel, K. I. Zeller, C. V. Dang, and J. T. Mendell.2005.c-Myc-regulated microRNAs modulate E2F1 expression. Nature.435 : 839-843.
32. Xiao, Y., C. Xu, J. Guan, Y. Ping, H. Fan, Y. Li, H. Zhao, and X. Li.2012.Discovering dysfunction of multiple microRNAs cooperation in disease by a conserved microRNA co-expression network. PLoS ONE.7 : e32201.
33. Xiao, Z. D., L. T. Diao, J. H. Yang, H. Xu, M. B. Huang, Y. J. Deng, H. Zhou, and L. H. Qu.2013.Deciphering the transcriptional regulation of microRNA genes in humans with ACTLocater. Nucleic Acids Res. 41 : e5.
34. Dang, C. V. 2012.MYC on the path to cancer. Cell.149 : 22-35.
35. Fernández-Hernando, C., and K. J. Moore.2011.MicroRNA modulation of cholesterol homeostasis. Arterioscler. Thromb. Vasc. Biol. 31 : 2378-2382.
36. Fernández-Hernando, C., C. M. Ramirez, L. Goedeke, and Y. Suarez.2013.MicroRNAs in metabolic disease. Arterioscler. Thromb. Vasc. Biol. 33 : 178-185.
37. Qu, F., X. Cui, Y. Hong, J. Wang, Y. Li, L. Chen, Y. Liu, Y. Gao, D. Xu, and Q. Wang.2013.MicroRNA-185 suppresses proliferation, invasion, migration, and tumorigenicity of human prostate cancer cells through targeting androgen receptor. Mol. Cell. Biochem. 377 : 121-130.
38. Xiang, Y., N. Ma, D. Wang, Y. Zhang, J. Zhou, G. Wu, R. Zhao, H. Huang, X. Wang, Y. Qiao, et al.MiR-152 and miR-185 co-contribute to ovarian cancer cells cisplatin sensitivity by targeting DNMT1 directly: a novel epigenetic therapy independent of decitabine. Oncogene.Epub ahead of print. January 13, 2013; doi:10.1038/ onc.2012.575.
39. Bensen, J. T., C. K. Tse, S. J. Nyante, J. S. Barnholtz-Sloan, S. R. Cole, and R. C. Millikan.2013.Association of germline microRNA SNPs in pre-miRNA flanking region and breast cancer risk and survival: the Carolina Breast Cancer Study. Cancer Causes Control.24: 1099-1109.
40. Imam, J. S., K. Buddavarapu, J. S. Lee-Chang, S. Ganapathy, C. Camosy, Y. Chen, and M. K. Rao.2010.MicroRNA-185 suppresses tumor growth and progression by targeting the Six1 oncogene in human cancers. Oncogene.29 : 4971-4979.
41. Liu, M., N. Lang, X. Chen, Q. Tang, S. Liu, J. Huang, Y. Zheng, and F. Bi.2011.miR-185 targets RhoA and Cdc42 expression and inhibits the proliferation potential of human colorectal cells. Cancer Lett. 301 : 151-160.
42. Zhang, Z., H. Tang, Z. Wang, B. Zhang, W. Liu, H. Lu, L. Xiao, X. Liu, R. Wang, X. Li, et al.2011.MiR-185 targets the DNA methyltransferases 1 and regulates global DNA methylation in human glioma. Mol. Cancer.10 : 124.
43. Wang, L., X. J. Jia, H. J. Jiang, Y. Du, F. Yang, S. Y. Si, and B. Hong.2013.MicroRNAs 185, 96, and 223 repress selective high-density lipoprotein cholesterol uptake through posttranscriptional inhibition. Mol. Cell. Biol. 33 : 1956-1964.
44. Hu, Z., W. J. Shen, F. B. Kraemer, and S. Azhar.2012.MicroRNAs 125a and 455 repress lipoprotein-supported steroidogenesis by targeting scavenger receptor class B type I in steroidogenic cells. Mol. Cell. Biol. 32 : 5035-5045.
45. Favier, M. L., P. E. Bost, C. Guittard, C. Demigne, and C. Remesy.997.The cholesterol-lowering effect of guar gum is not the result of a simple diversion of bile acids toward fecal excretion. Lipids.32 : 953-959.
46. Shum, Y. Y., N. Huang, G. Walter, A. Black, C. Sekerke, T. Chang, and L. R. Whitfield.1998.Development, validation, and interlaboratory comparison of an HMG-CoA reductase inhibition assay for quantitation of atorvastatin in plasma matrices. Ther. Drug Monit. 20 : 41-49.
47. Sun, L. P., J. Seemann, J. L. Goldstein, and M. S. Brown.2007.Sterol- regulated transport of SREBPs from endoplasmic reticulum to Golgi: Insig renders sorting signal in Scap inaccessible to COPII proteins. Proc. Natl. Acad. Sci. USA.104 : 6519-6526.
48. Sokolov, A., and A. Radhakrishnan.2010.Accessibility of cholesterol in endoplasmic reticulum membranes and activation of SREBP-2 switch abruptly at a common cholesterol threshold. J. Biol. Chem. 285 : 29480-29490.
49. Radhakrishnan, A., J. L. Goldstein, J. G. McDonald, and M. S. Brown.2008.Switch-like control of SREBP-2 transport triggered by small changes in ER cholesterol: a delicate balance. Cell Metab. 8 : 512-521.
50. Rodwell, V. W. 1972.Cholesterol regulation of hepatic 3-hydroxy-3-methylglutaryl-coenzyme A reductase. Biochem. J. 128 : 16P.
51. Rodwell, V. W. 1972.Cholesterol regulation of hepatic HMG-CoA reductase. Biochem. Soc. Symp. 35 : 295-301.
52. Saini, H. K., S. Griffiths-Jones, and A. J. Enright.2007.Genomic analysis of human microRNA transcripts. Proc. Natl. Acad. Sci. USA.04 : 17719-17724.
53. Shao, W., and P. J. Espenshade.2012.Expanding roles for SREBP in metabolism. Cell Metab. 16 : 414-419.
54. Jeon, T. I., and T. F. Osborne.2012.SREBPs: metabolic integrators in physiology and metabolism. Trends Endocrinol. Metab. 23 : 65-72.
55. Moore, K. J., K. J. Rayner, Y. Suarez, and C. Fernandez-Hernando.2010. microRNAs and cholesterol metabolism. Trends Endocrinol. Metab. 21 : 699-706.
56. Moore, K. J., K. J. Rayner, Y. Suarez, and C. Fernandez-Hernando.2011.The role of microRNAs in cholesterol efflux and hepatic lipid metabolism. Annu. Rev. Nutr. 31 : 49-63.
57. Chang, J., E. Nicolas, D. Marks, C. Sander, A. Lerro, M. A. Buendia, C. Xu, W. S. Mason, T. Moloshok, R. Bort, et al.2004.miR-122, a mammalian liver-specific microRNA, is processed from hcr mRNA and may downregulate the high affinity cationic amino acid transporter CAT-1. RNA Biol. 1 : 106-113.
58. Rayner, K. J., C. C. Esau, F. N. Hussain, A. L. McDaniel, S. M. Marshall, J. M. van Gils, T. D. Ray, F. J. Sheedy, L. Goedeke, X. Liu, et al.2011.Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides. Nature.478 : 404-407.
59. Najafi-Shoushtari, S. H., F. Kristo, Y. Li, T. Shioda, D. E. Cohen, R. E. Gerszten, and A. M. Naar.2010.MicroRNA-33 and the SREBP host genes cooperate to control cholesterol homeostasis. Science.328 : 1566-1569.
60. Li, Y., S. Xu, M. M. Mihaylova, B. Zheng, X. Hou, B. Jiang, O. Park, Z. Luo, E. Lefai, J. Y. Shyy, et al.2011.AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice. Cell Metab. 13 : 376-388.
61. Horton, J. D., Y. Bashmakov, I. Shimomura, and H. Shimano.1998.Regulation of sterol regulatory element binding proteins in livers of fasted and refed mice. Proc. Natl. Acad. Sci. USA.95 : 5987-5992.
62. Kim, J. B., P. Sarraf, M. Wright, K. M. Yao, E. Mueller, G. Solanes, B. B. Lowell, and B. M. Spiegelman.1998.Nutritional and insulin regulation of fatty acid synthetase and leptin gene expression through ADD1/SREBP1. J. Clin. Invest. 101 : 1-9.
63. Bizeau, M. E., P. S. MacLean, G. C. Johnson, and Y. Wei.2003.Skeletal muscle sterol regulatory element binding protein-1c decreases with food deprivation and increases with feeding in rats. J. Nutr. 133 : 1787-1792.
64. Commerford, S. R., L. Peng, J. J. Dube, and R. M. O'Doherty.2004.In vivo regulation of SREBP-1c in skeletal muscle: effects of nutritional status, glucose, insulin, and leptin. Am. J. Physiol. Regul. Integr. Comp. Physiol. 287 : R218-R227.
65. Azzout-Marniche, D., D. Becard, C. Guichard, M. Foretz, P. Ferre, and F. Foufelle.2000.Insulin effects on sterol regulatory-elementbinding protein-1c (SREBP-1c) transcriptional activity in rat hepatocytes. Biochem. J. 350 : 389-393.
66. Foretz, M., C. Pacot, I. Dugail, P. Lemarchand, C. Guichard, X. Le Liepvre, C. Berthelier-Lubrano, B. Spiegelman, J. B. Kim, P. Ferre, et al.1999.ADD1/SREBP-1c is required in the activation of hepatic lipogenic gene expression by glucose. Mol. Cell. Biol. 19 : 3760-3768.
67. Lehmann, J. M., S. A. Kliewer, L. B. Moore, T. A. Smith-Oliver, B. B. Oliver, J. L. Su, S. S. Sundseth, D. A. Winegar, D. E. Blanchard, T. A.Spencer, et al.1997.Activation of the nuclear receptor LXR by .oxysterols defines a new hormone response pathway. J. Biol. Chem. 272 : 3137-3140.
68. Janowski, B. A., M. J. Grogan, S. A. Jones, G. B. Wisely, S. A. Kliewer, E. J. Corey, and D. J. Mangelsdorf.1999.Structural requirements of ligands for the oxysterol liver X receptors LXRalpha and LXRbeta. Proc. Natl. Acad. Sci. USA.96 : 266-271.
69. Tontonoz, P., and D. J. Mangelsdorf.2003.Liver X receptor signaling pathways in cardiovascular disease. Mol. Endocrinol. 17 : 985-993.
70. Xu, J., M. T. Nakamura, H. P. Cho, and S. D. Clarke.1999.Sterol regulatory element binding protein-1 expression is suppressed by dietary polyunsaturated fatty acids. A mechanism for the coordinate suppression of lipogenic genes by polyunsaturated fats. J. Biol. Chem. 274 : 23577-23583.
71. Xu, J., M. Teran-Garcia, J. H. Park, M. T. Nakamura, and S. D. Clarke.2001.Polyunsaturated fatty acids suppress hepatic sterol regulatory element-binding protein-1 expression by accelerating transcript decay. J. Biol. Chem. 276 : 9800-9807.
72. Hannah, V. C., J. Ou, A. Luong, J. L. Goldstein, and M. S. Brown.2001.Unsaturated fatty acids down-regulate srebp isoforms 1a and 1c by two mechanisms in HEK-293 cells. J. Biol. Chem. 276 : 4365-4372.
73. Price, P. T., C. M. Nelson, and S. D. Clarke.2000.Omega-3 polyunsaturated fatty acid regulation of gene expression. Curr. Opin. Lipidol. 11 : 3-7.
74. Nakamura, M. T., Y. Cheon, Y. Li, and T. Y. Nara.2004.Mechanisms of regulation of gene expression by fatty acids. Lipids.39 : 1077-1083.
75. Field, F. J., E. J. Albright, and S. N. Mathur.1987.Effect of dietary n-3 fatty acids on HMG-CoA reductase and ACAT activities in liver and intestine of the rabbit. J. Lipid Res. 28 : 50-58.
76. Field, F. J., and R. G. Salome.1982.Effect of dietary fat saturation, cholesterol and cholestyramine on acyl-CoA: cholesterol acyltransferase activity in rabbit intestinal microsomes. Biochim. Biophys. Acta.712 : 557-570.
77. Shimano, H., I. Shimomura, R. E. Hammer, J. Herz, J. L. Goldstein, M. S. Brown, and J. D. Horton.1997.Elevated levels of SREBP-2 and cholesterol synthesis in livers of mice homozygous for a targeted disruption of the SREBP-1 gene. J. Clin. Invest. 100 : 2115-2124.
78. Liang, G., J. Yang, J. D. Horton, R. E. Hammer, J. L. Goldstein, and M. S. Brown.2002.Diminished hepatic response to fasting/refeeding and liver X receptor agonists in mice with selective deficiency of sterol regulatory element-binding protein-1c. J. Biol. Chem. 277 : 9520-9528.
79. Leiva, A., H. Verdejo, M. L. Benitez, A. Martinez, D. Busso, and A. Rigotti.2011.Mechanisms regulating hepatic SR-BI expression and their impact on HDL metabolism. Atherosclerosis.217 : 299-307.
80. Zhao, Y., M. Pennings, C. L. Vrins, L. Calpe-Berdiel, M. Hoekstra, J. K. Kruijt, R. Ottenhoff, R. B. Hildebrand, R. van der Sluis, W. Jessup, et al.2011.Hypocholesterolemia, foam cell accumulation, but no atherosclerosis in mice lacking ABC-transporter A1 and scavenger receptor BI. Atherosclerosis.218 : 314-322.
81. Xiao, X., and B. L. Song.2013.SREBP: a novel therapeutic target. Acta Biochim. Biophys. Sin. (Shanghai).45 : 2-10.
82. Moon, Y. A., G. Liang, X. Xie, M. Frank-Kamenetsky, K. Fitzgerald, V. Koteliansky, M. S. Brown, J. L. Goldstein, and J. D. Horton.2012.The Scap/SREBP pathway is essential for developing diabetic fatty liver and carbohydrate-induced hypertriglyceridemia in animals. Cell Metab. 15 : 240-246.
83. Tang, J. J., J. G. Li, W. Qi, W. W. Qiu, P. S. Li, B. L. Li, and B. L. Song.2011.Inhibition of SREBP by a small molecule, betulin, improves hyperlipidemia and insulin resistance and reduces atherosclerotic plaques. Cell Metab. 13 : 44-56.